Providence Capital Advisors LLC Acquires 7,748 Shares of Cigna Group $CI

Providence Capital Advisors LLC boosted its stake in shares of Cigna Group (NYSE:CIFree Report) by 1,016.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,510 shares of the health services provider’s stock after buying an additional 7,748 shares during the quarter. Providence Capital Advisors LLC’s holdings in Cigna Group were worth $2,453,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CI. Solstein Capital LLC acquired a new position in shares of Cigna Group in the second quarter worth approximately $29,000. Harbor Capital Advisors Inc. increased its position in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 49 shares during the period. Chilton Capital Management LLC bought a new position in Cigna Group during the 2nd quarter worth approximately $30,000. Princeton Global Asset Management LLC lifted its position in shares of Cigna Group by 115.6% in the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock worth $32,000 after purchasing an additional 52 shares during the period. Finally, Quaker Wealth Management LLC boosted its stake in shares of Cigna Group by 201.0% in the 2nd quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock valued at $35,000 after purchasing an additional 211 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

CI has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. The Goldman Sachs Group dropped their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. Finally, Robert W. Baird dropped their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $329.84.

Read Our Latest Stock Analysis on Cigna Group

Cigna Group Stock Performance

NYSE CI opened at $294.75 on Tuesday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a market cap of $78.74 billion, a P/E ratio of 13.29, a PEG ratio of 1.04 and a beta of 0.27. The company has a fifty day simple moving average of $275.19 and a 200 day simple moving average of $283.70. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the company earned $6.64 earnings per share. The business’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 27.23%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.